https://www.delhipolicygroup.org/publication/policy-briefs/the-international-politics-of-covid-19-vaccines-how-did-we-reach-here.html - As the COVID-19 pandemic rages, the world faces serious vaccine shortages. After 170 million cases, over 3.5 million deaths and eighteen months, nations continue to grapple over a mechanism for ensuring the equitable distribution of vaccines. The state of the vaccination project is worrisome, as the gap in vaccine availability between the developed and developing countries widens day-by-day. According to Science magazine, nearly 85% of total doses administered till May 25, 2021 have gone to rich and middle-income countries.
- Drug companies want to protect their intellectual property rights to manufacture and sell COVID-19 vaccines, while India, South Africa, and other developing nations want to end IP protections in order to share how to make vaccines more widely.
- A letter sent to the US President argues that IP protections have been essential for developing vaccines quickly and should not be waived, as removing them could undermine the global response and vaccine confidence. However, others argue a waiver could help scale up vaccine production and access in developing countries.
- The letter uses techniques like flattery, establishing cooperation, and shifting blame to support maintaining the status quo of IP protections. It aims to convince the US not to support a proposed waiver of certain IP rules being
This document provides a summary of key trends related to vaccination. It discusses how vaccine hesitancy has increased around the world in recent decades, potentially undermining public health efforts to respond to the COVID-19 pandemic. Employers have an important role to play in encouraging vaccination and responsible behavior during pandemics in order to protect public health and enable businesses and the economy to return to normal. However, the spread of misinformation about health issues and vaccines has undermined trust and compliance with public health recommendations. As research on a COVID-19 vaccine continues, effectively countering misinformation will be important for building confidence in any potential vaccine.
What is vaccine diplomacy, vaccine diplomacy in south Asia (China, India, Bangladesh) and also USA and Britain are being discussed in this presentation slide. Also can see some static figure for better understanding. Below the topic are being covered:
1. Diplomacy with unprivileged country.
2. Victim of vaccine diplomacy.
3. Why china hide the vaccine rate of Bangladesh from other country.
4. Latest update of vaccine diplomacy in Bangladesh.
A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.
The Future Landscape of Covid-19 Vaccine MarketMehdiMehdiyev4
We believe that assessing the potential market for COVID-
19 vaccines is necessary in terms of reevaluating the risk/reward ratio of certain vaccine developing companies.
In addition, an overly utopian outlook for a potential COVID-19 vaccine market may lead to
disappointment and negatively affect future vaccine developers. And this concerns us more.
China Vaccine Market, Size, Forecast 2023-2027Renub Research
Renub Research has recently released a report named "China Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2027," providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the China Vaccine Market.
The document provides an overview of the current Canadian vaccine environment, including:
1) The global and Canadian vaccine markets, which are growing significantly but still represent a small portion of pharmaceutical markets.
2) The complex process required for introducing new vaccines, which involves regulatory approval, funding, recommendations, and infrastructure.
3) The key players in Canada's vaccine system, including manufacturers, government agencies, medical societies, and others.
4) Recommendations to improve Canada's vaccine system by recognizing its value, encouraging investment, streamlining processes, and ensuring resources for programs and surveillance.
- Drug companies want to protect their intellectual property rights to manufacture and sell COVID-19 vaccines, while India, South Africa, and other developing nations want to end IP protections in order to share how to make vaccines more widely.
- A letter sent to the US President argues that IP protections have been essential for developing vaccines quickly and should not be waived, as removing them could undermine the global response and vaccine confidence. However, others argue a waiver could help scale up vaccine production and access in developing countries.
- The letter uses techniques like flattery, establishing cooperation, and shifting blame to support maintaining the status quo of IP protections. It aims to convince the US not to support a proposed waiver of certain IP rules being
This document provides a summary of key trends related to vaccination. It discusses how vaccine hesitancy has increased around the world in recent decades, potentially undermining public health efforts to respond to the COVID-19 pandemic. Employers have an important role to play in encouraging vaccination and responsible behavior during pandemics in order to protect public health and enable businesses and the economy to return to normal. However, the spread of misinformation about health issues and vaccines has undermined trust and compliance with public health recommendations. As research on a COVID-19 vaccine continues, effectively countering misinformation will be important for building confidence in any potential vaccine.
What is vaccine diplomacy, vaccine diplomacy in south Asia (China, India, Bangladesh) and also USA and Britain are being discussed in this presentation slide. Also can see some static figure for better understanding. Below the topic are being covered:
1. Diplomacy with unprivileged country.
2. Victim of vaccine diplomacy.
3. Why china hide the vaccine rate of Bangladesh from other country.
4. Latest update of vaccine diplomacy in Bangladesh.
A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.
The Future Landscape of Covid-19 Vaccine MarketMehdiMehdiyev4
We believe that assessing the potential market for COVID-
19 vaccines is necessary in terms of reevaluating the risk/reward ratio of certain vaccine developing companies.
In addition, an overly utopian outlook for a potential COVID-19 vaccine market may lead to
disappointment and negatively affect future vaccine developers. And this concerns us more.
China Vaccine Market, Size, Forecast 2023-2027Renub Research
Renub Research has recently released a report named "China Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2027," providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the China Vaccine Market.
The document provides an overview of the current Canadian vaccine environment, including:
1) The global and Canadian vaccine markets, which are growing significantly but still represent a small portion of pharmaceutical markets.
2) The complex process required for introducing new vaccines, which involves regulatory approval, funding, recommendations, and infrastructure.
3) The key players in Canada's vaccine system, including manufacturers, government agencies, medical societies, and others.
4) Recommendations to improve Canada's vaccine system by recognizing its value, encouraging investment, streamlining processes, and ensuring resources for programs and surveillance.
Research Dive has recently added a new report on Human Papillomavirus Vaccine Market Size Share which provides a succinct analysis of the market size, revenue forecast, and the regional landscape of Human Papillomavirus Vaccine Market Size Share
LEVERAGING PRIVATE-PUBLIC PARTNERSHIPS IN COVID-19 PANDEMIC RESPONSEiQHub
The document discusses leveraging private-public partnerships (PPPs) in COVID-19 pandemic response. It provides context on global vaccine trends pre-COVID, then discusses the major impacts of the pandemic on clinical development, trials, and manufacturing. It highlights the roles of developing country vaccine manufacturers and IVI in responding through PPPs. IVI in particular has built partnerships across regions and leveraged over $30 million to develop affordable vaccines for cholera, typhoid and other diseases.
GLOBAL VACCINATION: HOW THE EVOLVING HEALTHCARE INFRASTRUCTURE IS SUPPORTING ...Anayasharma10
COVID-19 (coronavirus) vaccines have started becoming accessible in most countries and are probably a severe product in fighting the pandemic in 2021. Several vaccines are already in the development trails or phase three trials that have reported promising data in the initial phase, with some receiving authorization for use.
This document discusses the concept of "megafunds" to help fund research and development for rare diseases. It notes that current sources of funding like venture capital and philanthropic venture capital are not enough to develop treatments for the over 7,000 known rare diseases. It proposes creating large pooled investment funds or "megafunds" that would attract funding from institutional investors by issuing bonds or debt backed by the intellectual property of a portfolio of drug development programs. This could open access to a larger pool of capital to fund more rare disease research more efficiently and at a reduced risk level through diversification. It provides examples of past proposals and discussions around this concept as a potential new model to help bridge the "valley of death"
The document discusses the impact of COVID-19 on the life science and healthcare industry in the US. It notes that the pandemic has significantly strained healthcare capacity and caused spending on the sector to increase. The pharmaceutical and medical equipment segments have seen high demand for COVID-19 tests, supplies, and research into vaccines and treatments. Government relief packages have allocated billions towards healthcare services, facilities, and supporting the development of response efforts. Overall, the pandemic is driving major changes across the industry and highlighting vulnerabilities in the US healthcare system.
The Fauci/COVID-19 Dossier
This work was supported, in part, by a fund-raising effort in which approximately 330 persons contributed funds in support
of the New Earth technology team and Urban Global Health Alliance. It is released under a Creative Commons license CCBY-NC-SA
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of December 2021. However, concerns are raised about the capacity to produce enough doses to vaccinate those aged 18-44 by that time.
2) The previous single procurement model, where the central government procured vaccines for all, has been replaced with a liberalized policy where states must procure vaccines for those 18-44 from private manufacturers.
3) Differential pricing has been introduced, with states paying more per dose than the central government's rate. This is argued to disproportionately impact certain states and individuals.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
Although other departments of the government shall look after market completion, polices etc. BMRC is going beyond jurisdiction to create an oligopoly situation of three brands of vaccine and depriving the nation from an own successful research. Bangladesh could be proud of global standard research by a local company.
Post Covid Era A Positive Correlation with Increased Number of Anxiety Disordersijtsrd
Covid In the context of the Post COVID 19 era after vaccinations, it appears likely that there will be substantial increases in anxiety and depression, substance use, loneliness, and domestic violence and with schools closed, there is a very real possibility of an epidemic of child abuse. This concern is so significant that the UK has issued psychological first aid guidance from Mental Health UK. The magnitude of deaths over a short period of time is an international tragedy on a historic scale. Focusing on the US, the number of deaths currently attributable to COVID 19 is nearly 4 times the number killed during the Vietnam War. This interpersonal loss at a massive scale is compounded by societal disruption. The necessary social distancing and quarantine measures implemented as mitigation strategies have significantly amplified emotional turmoil by substantially changing the social fabric by which individuals, families, communities, and nations cope with tragedy. The effect is multidimensional disruption of employment, finances, education, health care, food security, transportation, recreation, cultural and religious practices, and the ability of personal support networks and communities to come together and grieve. Dr. Bharat Kumar Marmath "Post Covid Era- A Positive Correlation with Increased Number of Anxiety Disorders" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd46279.pdf Paper URL: https://www.ijtsrd.com/medicine/other/46279/post-covid-era-a-positive-correlation-with-increased-number-of-anxiety-disorders/dr-bharat-kumar-marmath
Petition to the Senate Alliance for Covid Resilient PhilippinesBerean Guide
This document is a petition submitted to the Senate of the Philippines requesting two actions: 1) That the Senate not consider or disapprove any bill making COVID-19 vaccination mandatory, and 2) That the Senate investigate issues related to the COVID-19 pandemic and vaccine rollout. The petition raises concerns about mandatory vaccination violating constitutional rights and questions whether the pandemic is truly a pandemic or a "plandemic." It argues that SARS-CoV-2 is a manufactured virus, citing patents and a pre-pandemic conference, and that the vaccines do not provide true immunity. The petition requests expert testimony on these issues.
This document summarizes the key findings of a report on the global vaccine market forecast from 2012 to 2017. It includes an analysis of major vaccines currently on the market and in development pipelines, as well as the competitive landscape and market potential in key geographical regions such as the US, Europe, India, and China. The report methodology involved extensive secondary and primary research on vaccine manufacturers, industry reports, clinical studies and government databases to analyze market trends, size, growth opportunities and challenges in the global vaccine industry.
The document discusses how the COVID-19 pandemic highlighted the globalization and interconnectedness of the US healthcare system. It notes that early in the pandemic, the US faced shortages of personal protective equipment and medical supplies due to disruptions in the global supply chain. Further, it outlines how the US relies on other countries, especially China, for manufacturing of drugs, devices, and components essential to modern healthcare. The pandemic also demonstrated how telemedicine has allowed other nations like India to provide remote services to US providers, and how medical tourism allows US citizens to access lower-cost procedures abroad.
Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.
Taking The Pulse of Medtech innovation_Pitchbook, Dec, 2021Levi Shapiro
Report by Pitchbook (a Morningstar company), December, 2021- Taking the Pulse of Medtech Innovation. Medtech versus biotech: A capital investment comparison of the life sciences subsectors.
The red-hot life sciences industry has seen incredible growth in the last decade as the biomedical revolution of the early 21st century has gained traction. Key discoveries, ranging from the development of recombinant protein production to bioprosthetic implants to genome engineering, have propelled capital investment from VC investors to the tune of$20 billion annually for the past three years, with over $44 billion already deployed to life sciences companies in 2021 alone. Given large-cap multinational companies’ aversion to investing financial and human capital into high-risk early-stage research & development (R&D) projects, innovation within life sciences has fallen upon startups and venture-backed companies.
India and China Relations marked Instruction Trade Program (EEP) in 2006, which is an umbrella understanding for instructive participation between the two nations. Under this understanding, government grants are granted to the understudies, by the two sides, in perceived establishments of higher learning in each other's country.
India's Defence industry is a pivotal key area for the country. With around 14.4 lakh (1.44 million) dynamic staff, India has one of the world's biggest military powers. With around 51 lakh (5.1 million) volunteers, it flaunts the world's biggest volunteer military.
More Related Content
Similar to The international-politics-of-covid-19-vaccines-how-did-we-reach-here-2532
Research Dive has recently added a new report on Human Papillomavirus Vaccine Market Size Share which provides a succinct analysis of the market size, revenue forecast, and the regional landscape of Human Papillomavirus Vaccine Market Size Share
LEVERAGING PRIVATE-PUBLIC PARTNERSHIPS IN COVID-19 PANDEMIC RESPONSEiQHub
The document discusses leveraging private-public partnerships (PPPs) in COVID-19 pandemic response. It provides context on global vaccine trends pre-COVID, then discusses the major impacts of the pandemic on clinical development, trials, and manufacturing. It highlights the roles of developing country vaccine manufacturers and IVI in responding through PPPs. IVI in particular has built partnerships across regions and leveraged over $30 million to develop affordable vaccines for cholera, typhoid and other diseases.
GLOBAL VACCINATION: HOW THE EVOLVING HEALTHCARE INFRASTRUCTURE IS SUPPORTING ...Anayasharma10
COVID-19 (coronavirus) vaccines have started becoming accessible in most countries and are probably a severe product in fighting the pandemic in 2021. Several vaccines are already in the development trails or phase three trials that have reported promising data in the initial phase, with some receiving authorization for use.
This document discusses the concept of "megafunds" to help fund research and development for rare diseases. It notes that current sources of funding like venture capital and philanthropic venture capital are not enough to develop treatments for the over 7,000 known rare diseases. It proposes creating large pooled investment funds or "megafunds" that would attract funding from institutional investors by issuing bonds or debt backed by the intellectual property of a portfolio of drug development programs. This could open access to a larger pool of capital to fund more rare disease research more efficiently and at a reduced risk level through diversification. It provides examples of past proposals and discussions around this concept as a potential new model to help bridge the "valley of death"
The document discusses the impact of COVID-19 on the life science and healthcare industry in the US. It notes that the pandemic has significantly strained healthcare capacity and caused spending on the sector to increase. The pharmaceutical and medical equipment segments have seen high demand for COVID-19 tests, supplies, and research into vaccines and treatments. Government relief packages have allocated billions towards healthcare services, facilities, and supporting the development of response efforts. Overall, the pandemic is driving major changes across the industry and highlighting vulnerabilities in the US healthcare system.
The Fauci/COVID-19 Dossier
This work was supported, in part, by a fund-raising effort in which approximately 330 persons contributed funds in support
of the New Earth technology team and Urban Global Health Alliance. It is released under a Creative Commons license CCBY-NC-SA
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of December 2021. However, concerns are raised about the capacity to produce enough doses to vaccinate those aged 18-44 by that time.
2) The previous single procurement model, where the central government procured vaccines for all, has been replaced with a liberalized policy where states must procure vaccines for those 18-44 from private manufacturers.
3) Differential pricing has been introduced, with states paying more per dose than the central government's rate. This is argued to disproportionately impact certain states and individuals.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
Although other departments of the government shall look after market completion, polices etc. BMRC is going beyond jurisdiction to create an oligopoly situation of three brands of vaccine and depriving the nation from an own successful research. Bangladesh could be proud of global standard research by a local company.
Post Covid Era A Positive Correlation with Increased Number of Anxiety Disordersijtsrd
Covid In the context of the Post COVID 19 era after vaccinations, it appears likely that there will be substantial increases in anxiety and depression, substance use, loneliness, and domestic violence and with schools closed, there is a very real possibility of an epidemic of child abuse. This concern is so significant that the UK has issued psychological first aid guidance from Mental Health UK. The magnitude of deaths over a short period of time is an international tragedy on a historic scale. Focusing on the US, the number of deaths currently attributable to COVID 19 is nearly 4 times the number killed during the Vietnam War. This interpersonal loss at a massive scale is compounded by societal disruption. The necessary social distancing and quarantine measures implemented as mitigation strategies have significantly amplified emotional turmoil by substantially changing the social fabric by which individuals, families, communities, and nations cope with tragedy. The effect is multidimensional disruption of employment, finances, education, health care, food security, transportation, recreation, cultural and religious practices, and the ability of personal support networks and communities to come together and grieve. Dr. Bharat Kumar Marmath "Post Covid Era- A Positive Correlation with Increased Number of Anxiety Disorders" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd46279.pdf Paper URL: https://www.ijtsrd.com/medicine/other/46279/post-covid-era-a-positive-correlation-with-increased-number-of-anxiety-disorders/dr-bharat-kumar-marmath
Petition to the Senate Alliance for Covid Resilient PhilippinesBerean Guide
This document is a petition submitted to the Senate of the Philippines requesting two actions: 1) That the Senate not consider or disapprove any bill making COVID-19 vaccination mandatory, and 2) That the Senate investigate issues related to the COVID-19 pandemic and vaccine rollout. The petition raises concerns about mandatory vaccination violating constitutional rights and questions whether the pandemic is truly a pandemic or a "plandemic." It argues that SARS-CoV-2 is a manufactured virus, citing patents and a pre-pandemic conference, and that the vaccines do not provide true immunity. The petition requests expert testimony on these issues.
This document summarizes the key findings of a report on the global vaccine market forecast from 2012 to 2017. It includes an analysis of major vaccines currently on the market and in development pipelines, as well as the competitive landscape and market potential in key geographical regions such as the US, Europe, India, and China. The report methodology involved extensive secondary and primary research on vaccine manufacturers, industry reports, clinical studies and government databases to analyze market trends, size, growth opportunities and challenges in the global vaccine industry.
The document discusses how the COVID-19 pandemic highlighted the globalization and interconnectedness of the US healthcare system. It notes that early in the pandemic, the US faced shortages of personal protective equipment and medical supplies due to disruptions in the global supply chain. Further, it outlines how the US relies on other countries, especially China, for manufacturing of drugs, devices, and components essential to modern healthcare. The pandemic also demonstrated how telemedicine has allowed other nations like India to provide remote services to US providers, and how medical tourism allows US citizens to access lower-cost procedures abroad.
Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.
Taking The Pulse of Medtech innovation_Pitchbook, Dec, 2021Levi Shapiro
Report by Pitchbook (a Morningstar company), December, 2021- Taking the Pulse of Medtech Innovation. Medtech versus biotech: A capital investment comparison of the life sciences subsectors.
The red-hot life sciences industry has seen incredible growth in the last decade as the biomedical revolution of the early 21st century has gained traction. Key discoveries, ranging from the development of recombinant protein production to bioprosthetic implants to genome engineering, have propelled capital investment from VC investors to the tune of$20 billion annually for the past three years, with over $44 billion already deployed to life sciences companies in 2021 alone. Given large-cap multinational companies’ aversion to investing financial and human capital into high-risk early-stage research & development (R&D) projects, innovation within life sciences has fallen upon startups and venture-backed companies.
Similar to The international-politics-of-covid-19-vaccines-how-did-we-reach-here-2532 (20)
India and China Relations marked Instruction Trade Program (EEP) in 2006, which is an umbrella understanding for instructive participation between the two nations. Under this understanding, government grants are granted to the understudies, by the two sides, in perceived establishments of higher learning in each other's country.
India's Defence industry is a pivotal key area for the country. With around 14.4 lakh (1.44 million) dynamic staff, India has one of the world's biggest military powers. With around 51 lakh (5.1 million) volunteers, it flaunts the world's biggest volunteer military.
India's Strategic Partnerships are now and again connected with guard or security issues, however, a study of formal vital associations all over the planet uncovers that they can cover a wide scope of respective relations, from protection to training, wellbeing, and farming, and all the more usually, monetary relations, like an exchange, speculation, and banking."
Since DPG's beginning in 1994, we have remained ardently dedicated to these core values. Think Tanks and research organizations are also in India. In the late nineteenth and mid-twentieth hundreds of years, current Think Tanks were famous in the US, with most of the Think Tanks up in other English-talking nations. They would in general zero in on the monetary hardships connected with industrialization and urbanization preceding 1945.
Thinking better to develop effective strategies with dpgDelhi Policy Group
The DPG aims to propose research-based perspectives that are specifically targeted to involve India’s Continental Challenges. Issues that have gained national concern need a functional society to look over these matters in detail. All the approaches of a discussion are taken into consideration by the DPG before initiating strategies that secure India’s rising global influence as well as intensify India's Connectivity within the world.
India indonesia military relations shared vision of maritime cooperation in i...Delhi Policy Group
Being located at a distance of roughly 4483 kilometers, the strategic, diplomatic India Indonesia Military Relations between the two nations become important for both countries provided that they jointly acknowledge the threat China poses in the maritime domain.
Growing security and challenges of india's maritime emerging issuesDelhi Policy Group
The marine industry supervises, inspects, and takes necessary steps to minimize threats. The center of the entire India’s Security Challenges lies in China’s regressive turnout in the critical sea lanes in the south China sea.
https://www.delhipolicygroup.org/publication/policy-briefs/the-aukus-alliance-return-to-the-past.html - Shortly after taking over as Australia’s Prime Minister, Scott Morrison was asked how he would handle the delicate balance between the US and China. He replied, “Our relationships with each of these major partners are different and they’re both successful. Australia doesn’t have to choose and we won’t choose.
https://www.delhipolicygroup.org/publication/policy-briefs/the-relevance-of-boundaries.html - There has been considerable discussion over the past three decades on the need to make borders between nation-states irrelevant. While these demands for open borders between nation-states have a long history, there has been a renewed vigour to such arguments after the Maastricht treaty and the emergence of the European Union (EU).
Rejuvenating India-Japan Economic Relations: the Way ForwardDelhi Policy Group
https://www.delhipolicygroup.org/publication/policy-reports/rejuvenating-india-japan-economic-relations-the-way-forward.html - The economic and demographic profiles make the economic interests of India and Japan highly complementary with enormous potential to drive trade and investment relations between the two economies. The changing world economic order gives strategic dimension to the bilateral relations.
Review of India’s exports to the US in 2020: Need for a Vanijya BharatDelhi Policy Group
https://www.delhipolicygroup.org/publication/policy-reports/review-of-indias-exports-to-the-us-in-2020-need-for-a-vanijya-bharat.html - India’s exports to the United States declined by 2.78% during the COVID-19 battered year 2020-21, just as India’s global exports also shrank during this period. But much like the trend in recent years, India’s exports to the US performed relatively better compared to India’s overall exports, which declined by 7.1%, as per DGCIS figures.
The visit of US Secretary of State Antony J. Blinken to New Delhi on July 27-28, 2021, from atmospherics to substance, confirmed the forward momentum of the India-US comprehensive and global partnership. It signalled that bilateral relations are strong, diversified, consequential and mutually reinforcing, as both countries and the world continue to face the unprecedented challenge of the COVID-19 pandemic.
- The document discusses recent Indian policy decisions aimed at boosting indigenous defence capabilities and reducing reliance on imports.
- Key policies include establishing a negative import list, increasing the defence budget allocation for domestic procurement, and reforms to boost the private defence industry and startups.
- While the policies aim to enhance self-reliance, there are concerns about operational readiness if indigenous projects are delayed and about balancing self-reliance and security needs. Careful implementation will be needed.
https://www.delhipolicygroup.org/publication/policy-briefs/whither-indias-submarines.html - “Navy seeks amendment to 30-year plan, wants six nuclear boats”, announced a headline last week[1]. Over six years ago, another headline[2] had said, “Govt. approves construction of 7 stealth frigates, 6 nuclear-powered submarines”. The accompanying report informed readers that the Cabinet Committee on Security (CCS) had cleared the indigenous construction of seven stealth frigates under the Rs 50,000 crore Project 17A, as well as six nuclear-powered attack submarines. But if the Government had already approved the indigenous construction of six nuclear boats (SSNs) in 2015, why did the Navy still “want” them last week?
The Delhi Policy Group is an independent Indian think tank founded in 1994 that focuses on strategic and international issues of importance to India. It is non-partisan and funded by a non-profit trust. Over the decades, DPG has established itself as one of India's top security think tanks. Since 2016, DPG has expanded its focus areas to include India's regional and global role and policies in the Indo-Pacific. DPG aims to provide reliable and realist policy perspectives to both domestic and international audiences.
With over 1.4 million commissioned active personnel, India's armed forces are the fourth largest in the world. Also, as of now India has currently become an emerging 21st-century power. However, stuck in the rut of 20th-century conflicts, which is constraining India's defence posture and reducing India's military capability.
https://www.delhipolicygroup.org/publication/policy-reports/dj-vu-in-myanmar.html - Over the past two months, Myanmar has plunged into a political crisis. Myanmar’s tentative political transition towards democracy, which started in 2010 and gained momentum after the 2015 elections, has been reversed. The military (Tatmadaw) has staged a coup d’état and arrested democratically elected leaders, including President Win Myint and State Counsellor Daw Aung San Suu Kyi.
The document discusses India's defence budget for the financial year 2021-2022. Some key points:
- The overall defence budget has increased by Rs. 24,792.62 crore over the previous year to Rs. 3,62,345.62 crore. However, as a percentage of GDP, it remains around 1.63%.
- There is a perception that the defence budget should be around 3% of GDP to adequately meet India's security needs, but there is no clear rationale for this figure or the current allocation.
- To determine what is an "enough" budget, allocation should be linked to the Long Term Integrated Capability Development Plan and address critical operational gaps across domains like land
https://www.delhipolicygroup.org/publication/policy-reports/foreign-security-and-trade-policy-challenges-of-2021.html - Founded in 1994, the Delhi Policy Group (DPG) is among India’s oldest think tanks with its primary focus on strategic and international issues of critical national interest. DPG is a non-partisan institution and is independently funded by a non-profit Trust. Over past decades, DPG has established itself in both domestic and international circles and is widely recognised today among the top security think tanks of India and of Asia’s major powers.
Institution of the Chief of Defence Staff: Evaluating the First YearDelhi Policy Group
1) A year ago, the post of Chief of Defence Staff was created to promote jointness among India's armed forces. General Bipin Rawat took on this role on January 1, 2020.
2) While the CDS aims to optimize joint operations, training, logistics, and promote indigenization, India's response to the China border conflict showed no differences from past single-service responses.
3) A new acquisition policy was introduced but reduced the role of the Integrated Defence Staff in decision making, against the goal of promoting joint procurement and planning. Overall, operational jointness and a unified military vision remain to be seen from the new CDS structure.
Acolyte Episodes review (TV series) The Acolyte. Learn about the influence of the program on the Star Wars world, as well as new characters and story twists.
Here is Gabe Whitley's response to my defamation lawsuit for him calling me a rapist and perjurer in court documents.
You have to read it to believe it, but after you read it, you won't believe it. And I included eight examples of defamatory statements/
El Puerto de Algeciras continúa un año más como el más eficiente del continente europeo y vuelve a situarse en el “top ten” mundial, según el informe The Container Port Performance Index 2023 (CPPI), elaborado por el Banco Mundial y la consultora S&P Global.
El informe CPPI utiliza dos enfoques metodológicos diferentes para calcular la clasificación del índice: uno administrativo o técnico y otro estadístico, basado en análisis factorial (FA). Según los autores, esta dualidad pretende asegurar una clasificación que refleje con precisión el rendimiento real del puerto, a la vez que sea estadísticamente sólida. En esta edición del informe CPPI 2023, se han empleado los mismos enfoques metodológicos y se ha aplicado un método de agregación de clasificaciones para combinar los resultados de ambos enfoques y obtener una clasificación agregada.
An astonishing, first-of-its-kind, report by the NYT assessing damage in Ukraine. Even if the war ends tomorrow, in many places there will be nothing to go back to.
Essential Tools for Modern PR Business .pptxPragencyuk
Discover the essential tools and strategies for modern PR business success. Learn how to craft compelling news releases, leverage press release sites and news wires, stay updated with PR news, and integrate effective PR practices to enhance your brand's visibility and credibility. Elevate your PR efforts with our comprehensive guide.
3. The International ‘Politics’ of COVID-19 Vaccines:
How Did We Reach Here?
By
Arun Sahgal and Ambuj Sahu
Contents
Introduction .............................................................................................................................. 1
The Collapse of COVAX ........................................................................................................ 1
Supply Chains Disruptions Hit the Developing World ..........................................2
The Quest for Intellectual Property Waiver ................................................................3
Cometh China and Russia...................................................................................................3
Conclusion .................................................................................................................................4
4. DPG Policy Brief Vol. VI, Issue 17 | 1
The International ‘Politics’ of COVID-19 Vaccines
The International ‘Politics’ of COVID-19 Vaccines:
How Did We Reach Here?
by
Arun Sahgal and Ambuj Sahu
Introduction
As the COVID-19 pandemic rages, the world faces serious vaccine shortages.
After 170 million cases, over 3.5 million deaths and eighteen months, nations
continue to grapple over a mechanism for ensuring the equitable distribution
of vaccines. The state of the vaccination project is worrisome, as the gap in
vaccine availability between the developed and developing countries widens
day-by-day. According to Science magazine, nearly 85% of total doses
administered till May 25, 2021 have gone to rich and middle-income countries.
The global vaccination drive is overrun by great power politics that have
compromised international efforts at vaccine accessibility. The COVAX
initiative, despite being a laudable multilateral initiative for wider global
availability, has hit problem after problem. The vaccine supplies are coagulated:
the West produces most of the vaccines; India and Russia struggle to scale up
their production; and the efficacy of Chinese vaccines is questionable. This is
exacerbated by the unavailability of raw materials, big-pharma profiteering,
and pharmaceutical lobbies that vehemently support intellectual property
controls over the vaccines at the cost of human health and survival. Moreover,
vaccine diplomacy has become a tool for great powers to garner international
influence. Where the West risks losing international turf as a trade-off to
inoculate its own population first, China and Russia have rolled-out their stocks
in the developing world to establish their soft power. What should have been a
mission to save humanity from the deadly virus has turned out to be a power-
grabbing contest for certain states and companies.
This brief traces the evolution of international politics around COVID-19
vaccination and outlines potential dangers of the current approach towards
global vaccine distribution.
The Collapse of COVAX
The biggest challenge to the global vaccination drive was always going to be
ensuring the supply of vaccines to poor countries. The identified solution was
COVAX - a global initiative to create a common pool of vaccines from which all
countries alike were to be allotted their share. It was executed through an
5. DPG Policy Brief Vol. VI, Issue 17 | 2
The International ‘Politics’ of COVID-19 Vaccines
Advanced Market Commitment (AMC), where the developed world would self-
finance their quota in advance to burden-share the costs for providing free
vaccines to the developing countries. The country-wise quota was set to be 20%
of the population, that would be revised once all members had met their quotas.
Although started in April 2020, COVAX will still miss the May-end target of
delivery by 190 million doses. What went wrong?
COVAX would have worked if it had remained the only source of vaccine
supply for all countries. However, rich countries directly negotiated with the
pharmaceutical companies for their quotas while booking through COVAX as
an insurance (for instance, the UK and EU signed deals for doses as much as
three times their population). This created a double whammy. On the demand
side, COVAX faced fund shortages as rich countries did not buy from it. On the
supply side, pharma companies made profits by selling their doses to rich
countries and did not divert their stocks adequately to the COVAX pool. As very
few suppliers turned up, the vaccine supply chains became deeply cluttered.
The low-income countries are most affected, as they are majorly dependent on
COVAX for vaccine supply. Then began the supply chain disruptions.
Supply Chains Disruptions Hit the Developing World
The rising demand for vaccines pressured the vaccine supply chains at
multiple levels. Firstly, vaccine nationalism in developed countries led to pre-
purchase of doses, often more than their immediate requirements. Although
hefty donations were pledged to COVAX, the initiative did not have enough
vaccines to buy because of this hoarding. Consequently, it was
disproportionately dependent on countries like India and China to meet the
global demand. Secondly, the export regulations on raw materials by the US
limited India’s capabilities to ramp up production. Thirdly, the global supply
chains suffered the ultimate blow when the devastating second wave struck
India in March-April this year. Despite being the world's largest vaccine
manufacturer, India had to divert its doses to address the imminent crisis at
home under relentless partisan political criticism. As COVAX heavily depended
on the Serum Institute of India (SII) for its supplies, vaccine delivery was
severely affected. SII now expects to resume overseas supply only by the late
2021.
At this juncture, the developing world had two choices - first, making a case at
the World Trade Organisation (WTO) for securing a temporary intellectual
property waiver on vaccines; and second, searching for alternate vaccine
supplies from Russia and China. The spill-over effects of exercising both
options has left the developed and developing worlds at loggerheads.
6. DPG Policy Brief Vol. VI, Issue 17 | 3
The International ‘Politics’ of COVID-19 Vaccines
The Quest for Intellectual Property Waiver
In December 2020, India and South Africa requested the World Trade
Organisation (WTO) to temporarily suspend the intellectual property rights to
COVID-19 diagnostic tools, treatments and vaccines during the pandemic. The
argument was that without these special measures, the rich countries will
benefit from the new technologies as they come on the market, whereas the
less economically developed will continue to be ravaged by the pandemic,
which in turn would rebound on both. The proposal was based on the principle
that intellectual property rights, such as patents, are preventing new medical
products from being available and affordable. A temporary prohibition, it was
opined, would enable various countries to start production early, rather than
manufacturing being concentrated in the hands of a small number of patent-
holders, allowing for rapid scalability deemed to be the need of the hour. Both
countries reiterated the draft proposal in May 2021, and were backed by 62
countries.
This waiver is strongly opposed by most developed countries on the grounds
that IPR de-regulation would hamper the production and accessibility of
quality vaccines. Moreover, the pharmaceutical companies based in the West
argue that such a waiver will hinder innovation in the field and degrade the
quality of the vaccines. They also questioned the technical capability of pharma
producers in developing countries to deliver safe vaccines in required
quantities. Lately, the United States has agreed to support IPR waivers, but only
for vaccines and only through a series of text-based negotiations. However, the
opponents of the proposal have still maintained their position on the ground
that “there is an ocean between this waiver proposal and what was suggested
by the US.” The EU is pursuing an even harder line than the US, and has put
forward an alternative that will make a deal on the temporary waiver even more
unlikely. This process is thus expected to take years to fructify, if indeed it does,
defeating the very purpose of meeting immediate requirements for vaccine
doses in the developing world. Commercial considerations and self-interest
seem to have prevailed to sequester long term monopoly rents for western big
pharma.
Cometh China and Russia
Meanwhile, vaccine diplomacy from China and Russia has filled the supply
vacuum created by the West and India. The reliability of these vaccines has long
been under question. For instance, China has not shared the data of the third-
phase clinical trials of their vaccines Sinopharm and Sinovac. The trials carried
out in the receiver countries have shown mixed results - from 50.7% efficacy in
7. DPG Policy Brief Vol. VI, Issue 17 | 4
The International ‘Politics’ of COVID-19 Vaccines
Brazil to 83.5% in Turkey. Despite this, China has exported over 265 million
doses so far, more than all other countries combined. Notwithstanding the
somewhat dubious efficacy benchmark, the WHO has granted emergency
approval to Sinopharm and Sinovac on the strength of China’s economic
muscle and contributions to international bodies. China has also replaced India
as the largest vaccine contributor to the COVAX initiative; its vaccine
diplomacy is clearly winning. Even though public opinion favours western
origin vaccines, their irregular supplies have forced peoples in the developing
world, especially in Latin America, West Asia, Southeast Asia and Eastern
Europe, to depend upon Chinese vaccines.
Russia has also advanced its vaccine diplomacy, albeit on a much smaller scale.
It was the first country to develop a COVID-19 vaccine. After early criticism, it
established its legitimacy in early 2021 when Sputnik-V trials reported 92%
efficacy. Although vaccine hesitancy looms in Russia itself (8.2% population
vaccinated), it has exported doses to 43 countries.
It is only recently that President Biden has announced that the US will donate
around 80 million doses, after it became clear that the West had visibly lagged
in its vaccine diplomacy.
Conclusion
Vaccines have become another weapon of global geopolitics and part of what
some have termed as global nationalism, to wield in the geopolitical struggle.
While rich nations vaccinate their populations at a scale of one dose per
second, the peoples in several developing and less developed countries await
their first dose. The higher-income countries are largely being driven by their
technological and IPR monopoly over vaccine development and focus on rapid
economic recoveries, largely because of increasing economic competition
with China. With the US and the West dragging their feet on global vaccine
outreach, Moscow and Beijing have set out to fill the vacuum through bilateral
accords. India’s unexpected vaccine shortages have resulted in not only
utilising its surge capacities for internal consumption, but also to import
additional quantities to vaccinate its population affected by a virulent second
wave. As a result, after extending help to 66 developing countries, the “Vaccine
Maitri” programme stands suspended.
Today, while the developed West is vaccinating its population at a rapid pace,
middle-income countries are struggling to meet demands and even worse, less
developed countries must wait for a minimum of two to three years to even
start their modest vaccine drives.
8. DPG Policy Brief Vol. VI, Issue 17 | 5
The International ‘Politics’ of COVID-19 Vaccines
The failure of vaccine supply chains also confirms that international
organisations like the WHO have become sclerotic and largely redundant. The
COVAX initiative could not ensure compliance from the developed world
because of their inward-looking attitudes, while the global health organisation
was rendered toothless right from the start of the pandemic. From its failure to
conduct an impartial enquiry into the origins of the COVID-19 virus to diluting
its regulatory standards and according emergency approval for Chinese
vaccines, the WHO has been arm-twisted and overwhelmed by great power
politics. At a time when perhaps there are more rising powers than ever before
in the course of history, the erosion of international organisations will only
pave the way for disruptions in world order and further undermine the
prospects of a tired and enfeebled multilateralism.
***
9. DPG Policy Brief Vol. VI, Issue 17 | 6
The International ‘Politics’ of COVID-19 Vaccines
Delhi Policy Group
Core 5A, 1st Floor,
India Habitat Centre, Lodhi Road
New Delhi - 110003
India
www.delhipolicygroup.org